Dihydro Tofacitinib Citrate Impurity
Dihydro Tofacitinib Citrate Impurity (CAS No: N/A) Or 3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)as a targeted immunomodulator(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate, Dihydro Tofacitinib Citrate is an impurity of Tofacitinib, tofacitinib inhibits JAK1, JAK2, which is investigated as a targeted immunomodulator.
Additional information on Dihydro Tofacitinib Citrate Impurity
VE008139
N/A
C16H22N6O . C6H8O7
506.51 g/mol
Tofacitinib
3-((3R, 4R)-3-((6, 7-dihydro-5H-pyrrolo[2, 3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1, 2, 3-tricarboxylate
N/A
Sci-Hub, Evaluation of the effect of fluconazole and ketoconazole on the pharmacokinetics of tofacitinib in healthy adult subjects, 10.1002/cpdd.71. (2014). Retrieved January 29, 2022, from Sci-hub.ee website: https://sci-hub.ee/https://doi.org/10.1002/cpdd.71 ?
In-stock
